基本资料 投资组合 财务数据 基金公告
汇添富创新医药混合C(024344) |
净值：
1.4524
|
日增长率：
-1.61%
|
累计净值：1.4524 | 2026-11-03 |
|
|
||||
| 股票代码 | 股票简称 | 持股数量(股) | 持股市值(元) | 占基金净值比(%) |
| 06990 | 科伦博泰生物 | 3,242,600.00 | 1,355,570,681.00 | 10.05 |
| 01093 | 石药集团 | 155,850,000.00 | 1,347,212,502.99 | 9.98 |
| 600276 | 恒瑞医药 | 27,578,929.00 | 1,301,725,448.80 | 9.65 |
| 01801 | 信达生物 | 14,396,000.00 | 1,211,683,694.08 | 8.98 |
| 002653 | 海思科 | 17,025,643.00 | 1,053,358,880.10 | 7.81 |
| 300765 | 石药创新 | 18,779,971.00 | 886,226,831.49 | 6.57 |
| 688506 | 百利天恒 | 3,513,710.00 | 850,317,820.00 | 6.30 |
| 01530 | 三生制药 | 59,509,500.00 | 846,464,282.48 | 6.27 |
| 688266 | 泽璟制药 | 5,892,731.00 | 648,200,410.00 | 4.80 |
| 02595 | 劲方医药-B | 10,079,000.00 | 285,516,500.94 | 2.12 |
| 01276 | 恒瑞医药 | 545,600.00 | 23,511,368.39 | 0.17 |
| 报告期 | 股票占净比(%) | 债券占净比(%) | 现金占净比(%) | 净资产(元) |
| 2026-09-30 | 88.93 | - | 10.22 | 13,494,624,408.27 |
| 2026-06-30 | 90.81 | - | 10.22 | 11,870,285,969.97 |
| 2026-03-31 | 89.74 | - | 10.97 | 12,126,186,595.65 |
| 2025-12-31 | 90.51 | - | 10.04 | 11,881,367,144.28 |
| 2025-09-30 | 93.82 | - | 6.52 | 13,473,977,322.85 |
微信公众号
证券之星APP
